TATACHEM — Tata Chemicals Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹285.84bn
- IN₹340.33bn
- IN₹167.89bn
- 83
- 49
- 35
- 59
2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Interim Report | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 41,841 | 36,582 | 29,543 | 26,157 | 19,160 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 19,394 | 20,587 | 17,454 | 23,766 | 32,430 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 80,983 | 77,989 | 66,457 | 87,450 | 81,640 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 50,293 | 61,699 | 66,792 | 77,899 | 89,200 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 269,049 | 276,888 | 283,372 | 338,433 | 350,840 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 39,486 | 70,249 | 44,634 | 70,960 | 49,040 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 145,637 | 147,911 | 140,472 | 155,904 | 153,630 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 123,413 | 128,977 | 142,900 | 182,529 | 197,210 |
Total Liabilities & Shareholders' Equity | 269,049 | 276,888 | 283,372 | 338,433 | 350,840 |
Total Common Shares Outstanding |